Chevy Chase Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,141	Closed	-$3.04M	–	629
2024 Q2	$3.04M	Sell	11,141 -453	-4%	-$132K	0.01%	535
2024 Q1	$4.01M	Sell	11,594 -98	-0.8%	-$32.2K	0.01%	529
2023 Q4	$3.78M	Sell	11,692 -48	-0.4%	-$15K	0.01%	529
2023 Q3	$4.21M	Sell	11,740 -539	-4%	-$208K	0.02%	504
2023 Q2	$4.66M	Sell	12,279 -233	-2%	-$94.8K	0.02%	503
2023 Q1	$5.99M	Buy	12,512 +127	+1%	+$59.5K	0.02%	476
2022 Q4	$5.21M	Sell	12,385 -707	-5%	-$285K	0.02%	493
2022 Q3	$5.46M	Buy	13,092 +16	+0.1%	+$7.98K	0.02%	479
2022 Q2	$6.47M	Buy	13,076 +81	+0.6%	+$42.2K	0.03%	466
2022 Q1	$7.32M	Buy	12,995 +37	+0.3%	+$22.3K	0.03%	473
2021 Q4	$9.79M	Sell	12,958 -238	-2%	-$178K	0.03%	426
2021 Q3	$9.84M	Sell	13,196 -538	-4%	-$403K	0.03%	415
2021 Q2	$8.85M	Sell	13,734 -728	-5%	-$443K	0.03%	442
2021 Q1	$8.26M	Sell	14,462 -1,033	-7%	-$612K	0.03%	456
2020 Q4	$9.03M	Sell	15,495 -365	-2%	-$208K	0.03%	428
2020 Q3	$8.18M	Sell	15,860 -1,340	-8%	-$679K	0.03%	417
2020 Q2	$7.77M	Buy	+17,200	New	+$7.59M	0.03%	422